Certification of medical device COLLAGENASE MB

Identification code: CZ.01.2.06/0.0/0.0/20_344/0026416

Expected finish of the project: 2023

 

COLLAGENASE MB is an innovative product that enables gentle separation of Lagerhans bodies from the donor pancreas. This ensures their better viability and function after transplantation. As part of the project, MB PHARMA will be provided with consulting services that will lead to the correct preparation of technical and administrative documents and to the successful notification of the COLLAGENASE MB product as a medical device.